237 related articles for article (PubMed ID: 24326256)
61. Vascular effects of linagliptin in non-obese diabetic mice are glucose-independent and involve positive modulation of the endothelial nitric oxide synthase (eNOS)/caveolin-1 (CAV-1) pathway.
Vellecco V; Mitidieri E; Gargiulo A; Brancaleone V; Matassa D; Klein T; Esposito F; Cirino G; Bucci M
Diabetes Obes Metab; 2016 Dec; 18(12):1236-1243. PubMed ID: 27460695
[TBL] [Abstract][Full Text] [Related]
62. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
63. Occipital blood-brain barrier permeability is an independent predictor of visual outcome in type 2 diabetes, irrespective of the retinal barrier: A longitudinal study.
Abuhaiba SI; Cordeiro M; Amorim A; Cruz Â; Quendera B; Ferreira C; Ribeiro L; Bernardes R; Castelo-Branco M
J Neuroendocrinol; 2018 Jan; 30(1):. PubMed ID: 29247551
[TBL] [Abstract][Full Text] [Related]
64. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules.
Xu H; Forrester JV; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):226-34. PubMed ID: 12506079
[TBL] [Abstract][Full Text] [Related]
65. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model.
Shin JY; Sohn J; Park KH
J Korean Med Sci; 2013 Apr; 28(4):608-13. PubMed ID: 23579598
[TBL] [Abstract][Full Text] [Related]
66. Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.
Pojoga LH; Romero JR; Yao TM; Loutraris P; Ricchiuti V; Coutinho P; Guo C; Lapointe N; Stone JR; Adler GK; Williams GH
Endocrinology; 2010 Mar; 151(3):1236-46. PubMed ID: 20097717
[TBL] [Abstract][Full Text] [Related]
67. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
68. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
Jiang F; Chen Q; Huang L; Wang Y; Zhang Z; Meng X; Liu Y; Mao C; Zheng F; Zhang J; Yan H
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120595
[TBL] [Abstract][Full Text] [Related]
69. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters.
Segal SS; Brett SE; Sessa WC
Am J Physiol; 1999 Sep; 277(3):H1167-77. PubMed ID: 10484439
[TBL] [Abstract][Full Text] [Related]
70. Diabetic eNOS-knockout mice develop accelerated retinopathy.
Li Q; Verma A; Han PY; Nakagawa T; Johnson RJ; Grant MB; Campbell-Thompson M; Jarajapu YP; Lei B; Hauswirth WW
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5240-6. PubMed ID: 20435587
[TBL] [Abstract][Full Text] [Related]
71. Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease.
Vacca O; El Mathari B; Darche M; Sahel JA; Rendon A; Dalkara D
J Vis Exp; 2015 Apr; (98):. PubMed ID: 25938717
[TBL] [Abstract][Full Text] [Related]
72. Regulation of Caveolin-1 Expression Determines Early Brain Edema After Experimental Focal Cerebral Ischemia.
Choi KH; Kim HS; Park MS; Kim JT; Kim JH; Cho KA; Lee MC; Lee HJ; Cho KH
Stroke; 2016 May; 47(5):1336-43. PubMed ID: 27012742
[TBL] [Abstract][Full Text] [Related]
73. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
Greenwood J; Howes R; Lightman S
Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
[TBL] [Abstract][Full Text] [Related]
74. The blood-retinal barriers.
Cunha-Vaz JG
Doc Ophthalmol; 1976 Oct; 41(2):287-327. PubMed ID: 1009819
[TBL] [Abstract][Full Text] [Related]
75. Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.
Liu H; Lessieur EM; Saadane A; Lindstrom SI; Taylor PR; Kern TS
Diabetologia; 2019 Dec; 62(12):2365-2374. PubMed ID: 31612267
[TBL] [Abstract][Full Text] [Related]
76. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth.
Lin MI; Yu J; Murata T; Sessa WC
Cancer Res; 2007 Mar; 67(6):2849-56. PubMed ID: 17363608
[TBL] [Abstract][Full Text] [Related]
77. Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.
Kim J; Kim CS; Lee YM; Jo K; Shin SD; Kim JS
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):691-7. PubMed ID: 22249316
[TBL] [Abstract][Full Text] [Related]
78. Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice.
Kim J; Kim CS; Lee IS; Lee YM; Sohn E; Jo K; Kim JH; Kim JS
Endocrine; 2014 Aug; 46(3):462-9. PubMed ID: 24287793
[TBL] [Abstract][Full Text] [Related]
79. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability.
Carmo A; Cunha-Vaz JG; Carvalho AP; Lopes MC
Nitric Oxide; 2000 Dec; 4(6):590-6. PubMed ID: 11139367
[TBL] [Abstract][Full Text] [Related]
80. Caveolin-1 deficiency increases cerebral ischemic injury.
Jasmin JF; Malhotra S; Singh Dhallu M; Mercier I; Rosenbaum DM; Lisanti MP
Circ Res; 2007 Mar; 100(5):721-9. PubMed ID: 17293479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
